Skip to main content.

Will P. Parker, MD

William Parker portrait
Assistant Professor, Urologic Surgery

Professional Background

William P. Parker, MD, is a practicing urologist at The University of Kanas Health System and an assistant professor at the University of Kansas Medical Center. He was born in Georgia and received his undergraduate degree at the University of Georgia before attending the Medical College of Georgia. He completed his urology residency at the University of Kansas Medical Center. Prior to joining our faculty, he completed a Society for Urologic Oncology (SUO) fellowship at the Mayo Clinic in Rochester, Minnesota.
Dr. Parker has written several peer-reviewed articles in the field of urology and serves as a reviewer for multiple publications, including European Urology, the Journal of Urology, and Urologic Oncology. He additionally serves as a reviewer for Practical Reviews in Urology, focusing on recent urologic literature pertaining to minimally invasive procedures. As a faculty member, Dr. Parker participates in the education of residents in the clinical management and surgical procedures associated with urologic oncology. Furthermore, he serves as the section editor of the Prostate Cancer Diagnosis and Screening section of the American Urologic Association (AUA) Core Curriculum, providing education to all urology residents and interested medical students.
Dr. Parker specializes in the treatment of all urologic malignancies, including bladder, kidney, testis, penile and prostate cancers. However, he has a special interest in prostate cancer, including the minimally invasive management of prostate cancer, the management of advanced, recurrent and metastatic prostate cancers using a multidisciplinary approach and the care of the prostate cancer survivor.

Education and Training
  • BS, Biochemistry and Molecular Biology AND Cellular Biology, University of Georgia, Athens, GA
  • MD, Medical Doctor, Medical College of Georgia, Augusta, GA
  • Internship, General Surgery, University of Kansas Medical Center, Kansas City, Kansas (KS)
  • Residency, Urology, University of Kansas Medical Center, Kansas City, Kansas (KS)
  • Clinical Fellowship, Urologic Oncology, Mayo Clinic, Rochester, Minnesota (MN)
Licensure, Accreditations & Certifications
  • ABU Board Certification , American Board of Urology
  • Medical License, Kansas Board of Healing Arts
  • Physician and Surgeon License, Missouri Board of Registration for the Healing Arts

  • Nehra, A, Parker, W., P, Haloi, R, Park, S., S, Mynderse, L., A, Lowe, V., J, Davis, B., J, Quevedo, J., F, Johnson, G., B, Kwon, E., D, Karnes, R., J. 2017. Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using 11C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging.. The Journal of urology
  • Gandaglia, G, Boorjian, S., A, Parker, W., P, Zaffuto, E, Fossati, N, Bandini, M, Dell'Oglio, P, Suardi, N, Montorsi, F, Karnes, R., J, Briganti, A. 2017. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis.. European urology, 72 (6), 910-917
  • Fossati, N, Parker, W., P, Karnes, R., J, Colicchia, M, Bossi, A, Seisen, T, Di Muzio, N, Cozzarini, C, Chiorda, B., N, Fiorino, C, Gandaglia, G, Bartkowiak, D, Wiegel, T, Shariat, S, Goldner, G, Battaglia, A, Joniau, S, Haustermans, K, De Meerleer, G, Fonteyne, V, Ost, P, Van Poppel, H, Montorsi, F, Briganti, A, Boorjian, S., A. 2018. More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis.. European urology
  • Parker, W., P, Evans, J., D, Stish, B., J, Park, S., S, Olivier, K, Choo, R, Nathan, M., A, Welch, B., T, Karnes, R., J, Mynderse, L., A, Pisansky, T., M, Kwon, E., D, Lowe, V., J, Davis, B., J. 2017. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.. International journal of radiation oncology, biology, physics, 97 (3), 526-535